Ling-Shuang Liu - JoVE Visualize

Showing results (11-20 of 15) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 15 results.

Journal of Materials Science. Materials in Medicine|July 14, 2016

Characterization and cytocompatibility of thermosensitive hydrogel embedded with chitosan nanoparticles for delivery of bone morphogenetic protein-2 plasmid DNADan-Dan Li, Jian-Feng Pan, Qiu-Xia Ji, et al.

Medicine|February 3, 2021

Responses to crizotinib and cabozantinib in patient with lung adenocarcinoma harboring mesenchymal-epithelial transition factor exon 14 skipping mutation: A case reportRuo-Yan Qin, Ling-Shuang Liu, Hui-Yong Zhang, et al.

Complementary Therapies in Medicine|February 11, 2016

Traditional Chinese Medicine treatment as maintenance therapy in advanced non-small-cell lung cancer: A randomized controlled trialYi Jiang, Ling-Shuang Liu, Li-Ping Shen, et al.

Clinical Lung Cancer|June 25, 2019

Traditional Chinese Medicine Treatment as Adjuvant Therapy in Completely Resected Stage IB-IIIA Non-Small-Cell Lung Cancer: Study Protocol for a Multicenter, Double-Blind, Randomized, Placebo-Controlled TrialYi Jiang, Ling-Shuang Liu, Li-Ping Shen, et al.

Integrative Cancer Therapies|July 31, 2024

Oral Decoctions Based on Qi-Yin Syndrome Differentiation After Adjuvant Chemotherapy in Resected Stage ΙΙΙA Non-Small Cell Lung Cancer: A Randomized Controlled TrialYi Jiang, Fang-Fang Liu, Yu-Qing Cai, et al.

Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 15 results.

Journal of Materials Science. Materials in Medicine|July 14, 2016

Characterization and cytocompatibility of thermosensitive hydrogel embedded with chitosan nanoparticles for delivery of bone morphogenetic protein-2 plasmid DNADan-Dan Li, Jian-Feng Pan, Qiu-Xia Ji, et al.

Medicine|February 3, 2021

Responses to crizotinib and cabozantinib in patient with lung adenocarcinoma harboring mesenchymal-epithelial transition factor exon 14 skipping mutation: A case reportRuo-Yan Qin, Ling-Shuang Liu, Hui-Yong Zhang, et al.

Complementary Therapies in Medicine|February 11, 2016

Traditional Chinese Medicine treatment as maintenance therapy in advanced non-small-cell lung cancer: A randomized controlled trialYi Jiang, Ling-Shuang Liu, Li-Ping Shen, et al.

Clinical Lung Cancer|June 25, 2019

Traditional Chinese Medicine Treatment as Adjuvant Therapy in Completely Resected Stage IB-IIIA Non-Small-Cell Lung Cancer: Study Protocol for a Multicenter, Double-Blind, Randomized, Placebo-Controlled TrialYi Jiang, Ling-Shuang Liu, Li-Ping Shen, et al.

Integrative Cancer Therapies|July 31, 2024

Oral Decoctions Based on Qi-Yin Syndrome Differentiation After Adjuvant Chemotherapy in Resected Stage ΙΙΙA Non-Small Cell Lung Cancer: A Randomized Controlled TrialYi Jiang, Fang-Fang Liu, Yu-Qing Cai, et al.

Pageof 2